#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy Progressive supranuclear palsy Leukaemia Pancreatic neuroendocrine tumour Hypoparathyroidism Pemphigus Leukocyte adhesion deficiency type I Rhabdomyosarcoma recurrent Friedreich's ataxia Arrhythmogenic right ventricular dysplasia White matter lesion Conjunctivitis allergic Prostate cancer Bladder cancer Fontan procedure More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Treatment Ewing’s sarcoma – Life with Disease Rhabdomyosarcoma recurrent – Treatment Lymphangiosarcoma – Diagnostics Skin angiosarcoma – Diagnostics Isodicentric chromosome 15 syndrome – Trials in Disease Proteus syndrome – Trials in Disease Small intestine leiomyosarcoma – Basic Information Soft tissue sarcoma – Treatment Waldenstrom’s macroglobulinaemia refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rifabutin Sulodexide Fingolimod Hydrochloride Linaclotide ALE.P02 Tocotrienol Eplerenone Levosimendan Gsk4011499 Insulin Human Dextran 70 Alendronic Acid Bi 1015550 Carbetocin Ponsegromab Dornase Alfa Rilvegostomig Etoposide Phosphate Naloxone Hydrochloride Lacosamide More therapies…

    Learn about Your Condition

    Ventricular tachycardia Pyelonephritis Enteritis Triple positive breast cancer Vulvar dysplasia Left ventricular dysfunction Cervix carcinoma recurrent Biliary tract operation Small intestine leiomyosarcoma Prostate cancer recurrent Senile dementia Rectosigmoid cancer Oesophageal carcinoma Hypothyroidism Osteomyelitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Italy The Netherlands Norway +3

  • Study of Indocyanine Green Angiography to Prevent Hypoparathyroidism in Patients Undergoing Total Thyroid Removal

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thyroidectomy
    • Hypoparathyroidism
    Investigated Drugs:
    • Indocyanine Green
    France

  • Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Rivaroxaban
    Austria Germany

  • Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neonatal respiratory distress syndrome
    Investigated Drugs:
    • Poractant Alfa
    • Phospholipid Fraction, Bovine Lung
    Germany

  • Study on the Effect of Clobetasol Propionate on Bone Mineral Density in Patients with Bullous Pemphigoid

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clobetasol Propionate
    France

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France
Previous Page
1 … 327 328 329 330 331 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!